The Swedish company Scint-X has secured SEK 22 million equity investment. NXT2B has, as a new investor, invested 14.4 million and the present owners Conor and Praktikerinvest fulfilled the investment round. . The funds will ensure that Scint-X can continue the commercialization of its products and to build up high-volume manufacturing capacity of x-ray scintillators.
Kista, Sweden - September 03, 2013
- Scint-X, the developer of a novel and
unique x-ray scintillator device based on its patented
structured scintillator technology, announced that it has raised
SEK 22 million in growth capital through a private placement to
NXT2B, Conor and Praktikerinvest. Venture capital firm NXT2B,
founded by Bengt Ågerup, is a new investor
Scint-X has its technology roots at KTH Royal Institute of
Technology in Sweden. The company has developed a patented
scintillator technology to serve the x-ray industry with
significantly higher resolution and image quality.
The funds will be used to further develop ongoing projects with
international customers and to build up high-volume manufacturing
capacity in Kista, Sweden. In addition, the patented technology
will be developed further.
"The investment enables us to further strengthen our leading
scintillator technology base, and to build up high-volume
manufacturing capacity of scintillators enabling usto take a strong
position on the international digital x-ray market. We have
proven our technology together with our present customers, and we
are extremely happy welcoming an additional professional investor
having a strong background from growth equity investments in
healthcare, medical devices and specialty pharmaceutical companies.
NXT2B has the industry knowledge and contacts from the medical
market that will give us even further insights into our customers'
"Scint-X has an innovative technology that we believe will
be beneficial in several applications including medical diagnostics
and Scint-X fits well into our investment focus", says
Alexander Kotsinas , Partner at NXT2B and new board member
For more information please
visit Scint-X at www.scint-x.com or contact:
James Quinn CEO at Scint-X: firstname.lastname@example.org, +49 174 6069 007
Alexander Kotsinas, Partner at NXT2B: email@example.com, , +46 73 500 1111
Scint-X develops and markets a
technology for enhancing the performance of x-ray digital
imaging detectors, based on its patented and innovative structured
scintillator technique. Scint-X enables its customers to
build x- ray systems with unprecedented image quality and with
very high resolution.
For more information, please visit www.scint-x.com
NXT2B is a leading venture
capital/private equity firm with focus on growth equity
investments in healthcare, medical devices and specialty
pharmaceutical companies. NXT2B also invests in technology and
consumer companies. NXT2B started in 2011 and has invested in more
than 30 companies . NXT2B supports its portfolio company management
teams to build market leading companies.
For more information, please visit www.nxt2b.com
Praktikertjänst is Sweden's
largest group of companies within the sector for private,
commercially operated dental care and healthcare, where the 2,120
shareholders themselves run the practices/laboratories throughout
the country. The shareholders are professionals who work as
dentists, dental technicians/laboratory managers, dental
hygienists, doctors, physiotherapists,
psychoanalysts/psychotherapists, nurses, midwives, and others. The
group also includes fifteen subsidiaries. Group sales 2011 was SEK
8.9 billion and the number of employees was 8,760.
Conor Venture Partners is a leading early-stage
technology VC investing in Nordic and the Baltics. Conor invests in
disruptive technologies in ICT, embedded systems, electronics, new
materials and optics.
For more information, please visit www.conor.vc
STING Capital is one of the few venture capital funds in Sweden
that invests at the earliest stages of
development - even before there is a finished product or paying
customers. STING Capital is a
commercial VC fund that takes big risk and expects high returns.
The early-stage VC fund is often the
first external investor to offer business ideas or concepts
financial support, and can invest up to SEK 4 million per
For more information, please visit www.stingcapital.com